María J. Rico

677 total citations
28 papers, 533 citations indexed

About

María J. Rico is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, María J. Rico has authored 28 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in María J. Rico's work include Immunotherapy and Immune Responses (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). María J. Rico is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). María J. Rico collaborates with scholars based in Argentina, United States and Brazil. María J. Rico's co-authors include O. Graciela Scharovsky, Mariano F. Zacarías Fluck, Pablo Matar, Gabriel A. Rabinovich, Diego O. Croci, Viviana R. Rozados, Stella Maris Pezzotto, V. R. Rozados, Mauricio Menacho-Márquez and Eduardo Roggero and has published in prestigious journals such as Cancer Research, Scientific Reports and Annals of Oncology.

In The Last Decade

María J. Rico

26 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María J. Rico Argentina 12 252 171 168 92 53 28 533
Viviana R. Rozados Argentina 16 264 1.0× 250 1.5× 200 1.2× 144 1.6× 73 1.4× 37 706
Vahid Karpisheh Iran 11 156 0.6× 216 1.3× 164 1.0× 101 1.1× 45 0.8× 19 500
Erin Sult United States 8 374 1.5× 255 1.5× 288 1.7× 51 0.6× 44 0.8× 10 797
Yuanzhang Fang China 13 190 0.8× 322 1.9× 93 0.6× 108 1.2× 45 0.8× 19 568
Fatemeh Karimi Dermani Iran 7 291 1.2× 247 1.4× 145 0.9× 132 1.4× 73 1.4× 8 587
Yunjiang Zhou China 15 145 0.6× 420 2.5× 106 0.6× 72 0.8× 62 1.2× 22 640
Marilina García‐Aranda Spain 12 376 1.5× 315 1.8× 181 1.1× 134 1.5× 123 2.3× 28 732
Dachuan Jin China 5 181 0.7× 169 1.0× 188 1.1× 46 0.5× 18 0.3× 6 511
Poulami Khan India 11 210 0.8× 334 2.0× 73 0.4× 143 1.6× 40 0.8× 15 542

Countries citing papers authored by María J. Rico

Since Specialization
Citations

This map shows the geographic impact of María J. Rico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María J. Rico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María J. Rico more than expected).

Fields of papers citing papers by María J. Rico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María J. Rico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María J. Rico. The network helps show where María J. Rico may publish in the future.

Co-authorship network of co-authors of María J. Rico

This figure shows the co-authorship network connecting the top 25 collaborators of María J. Rico. A scholar is included among the top collaborators of María J. Rico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María J. Rico. María J. Rico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rico, María J., et al.. (2024). Intestinal ABC transporters: Influence on the metronomic cyclophosphamide-induced toxic effect in an obese mouse mammary cancer model. Toxicology and Applied Pharmacology. 492. 117130–117130. 1 indexed citations
2.
Lombarte, Mercedes, María J. Rico, Viviana R. Rozados, et al.. (2024). Increased Osteoblastic and Osteocytic in Vitro Cell Viability by Yerba Mate (Ilex paraguariensis). Journal of Bone Metabolism. 31(2). 101–113. 3 indexed citations
3.
Martínez‐Marignac, Verónica L., V. R. Rozados, O. Graciela Scharovsky, et al.. (2021). Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment. Scientific Reports. 11(1). 8091–8091. 21 indexed citations
4.
5.
Scharovsky, O. Graciela, et al.. (2020). Achievements and challenges in the use of metronomics for the treatment of breast cancer. Biochemical Pharmacology. 175. 113909–113909. 11 indexed citations
6.
Garcı́a, Agustina, et al.. (2018). Repositioning of Anti-parasitic Drugs in Cyclodextrin Inclusion Complexes for Treatment of Triple-Negative Breast Cancer. AAPS PharmSciTech. 19(8). 3734–3741. 22 indexed citations
7.
8.
Rico, María J., et al.. (2018). Paclitaxel delivery system based on poly(lactide-co-glycolide) microparticles and chitosan thermo-sensitive gel for mammary adenocarcinoma treatment. Journal of Pharmacy and Pharmacology. 70(11). 1494–1502. 24 indexed citations
9.
Rico, María J., Eduardo Roggero, Stella Maris Pezzotto, et al.. (2017). Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay. Cancer Investigation. 35(6). 377–385. 3 indexed citations
10.
Rosé, Adriana, Nicolás André, Viviana R. Rozados, et al.. (2016). Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina. ecancermedicalscience. 10. 672–672. 10 indexed citations
11.
Rico, María J., et al.. (2016). Quality of Life in Patients with Metastatic Breast Cancer Treated with Metronomic Chemotherapy. Future Oncology. 12(10). 1233–1242. 15 indexed citations
12.
Rico, María J., et al.. (2015). Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response. Cancer Chemotherapy and Pharmacology. 77(2). 365–374. 41 indexed citations
13.
Rico, María J., et al.. (2014). Comparative Effectiveness of Two Metronomic Chemotherapy Schedules—Our Experience in the Preclinical Field. Cancer Investigation. 32(3). 92–98. 4 indexed citations
14.
Scharovsky, O. Graciela, et al.. (2014). A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting. Journal of Biomedical Science. 21(1). 52–52. 3 indexed citations
15.
Rico, María J., et al.. (2013). Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas. Annals of Oncology. 24(9). 2310–2316. 23 indexed citations
16.
Rico, María J., et al.. (2012). Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model.. PubMed. 34(1). 38–42. 7 indexed citations
17.
Rozados, Viviana R., et al.. (2009). The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With Cyclophosphamide. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 18(11). 601–605. 27 indexed citations
18.
Croci, Diego O., Mariano F. Zacarías Fluck, María J. Rico, et al.. (2007). Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunology Immunotherapy. 56(11). 1687–1700. 182 indexed citations
19.
Fluck, Mariano F. Zacarías, María J. Rico, Silvia Gervasoni, et al.. (2006). Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model. Cancer Immunology Immunotherapy. 56(2). 237–248. 12 indexed citations
20.
Rico, María J., Pablo Matar, Silvia Gervasoni, et al.. (2005). The transition to the metastatic phenotype of rat lymphoma cells involves up-regulation of IL-10 receptor expression and IL-10 secretion. Clinical & Experimental Metastasis. 22(2). 127–135. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Viviana R. Rozados Breakdown of academic impact, for papers by Vahid Karpisheh Breakdown of academic impact, for papers by Erin Sult Breakdown of academic impact, for papers by Yuanzhang Fang Breakdown of academic impact, for papers by Fatemeh Karimi Dermani Breakdown of academic impact, for papers by Yunjiang Zhou Breakdown of academic impact, for papers by Marilina García‐Aranda Breakdown of academic impact, for papers by Dachuan Jin Breakdown of academic impact, for papers by Poulami Khan
Rankless by CCL
2026